9 Result(s)

Article

Correction: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials

Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai… in Cardiovascular Diabetology (2023)

Article

Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials

Effects of antihyperglycemic therapies on cardiovascular and heart failure (HF) risks have varied widely across cardiovascular outcome trials (CVOTs), and underlying factors remain incompletely understood. We ...

Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai… in Cardiovascular Diabetology (2023)

Article

Metformin-associated lactic acidosis exacerbated by acute kidney injury in an overseas traveler

We report the case of metformin-associated lactic acidosis (MALA) exacerbated by acute kidney injury (AKI) in a 65-year-old Asian American woman who was an overseas traveler. She had vomiting and diarrhea befo...

Ayano Hayashi, Takuya Ishimura, Hisashi Sugimoto, Hiroyuki Suzuki… in CEN Case Reports (2022)

Article

Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study

Previous studies suggested that β-cell function markers such as fasting and postprandial serum C-peptide and C-peptide increment (FCPR, PCPR, and ΔCPR, respectively) may be useful in estimating glycemic respon...

Satoshi Yoshiji, Masashi Hasebe, Yorihiro Iwasaki, Kimitaka Shibue… in Diabetes Therapy (2022)

Article

Enlarged adrenal glands: the long-term consequence of Cushing’s disease

Yorihiro Iwasaki, Akihiro Hamasaki in Endocrine (2019)

Article

Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial

The 52-week monotherapy with the dipeptidyl peptidase-4 inhibitor sitagliptin and the sulphonylurea glimepiride on early-phase insulin secretion in Japanese patients with type 2 diabetes mellitus (T2DM) is not...

Yaeko Kondo, Norio Harada, Akihiro Hamasaki… in Diabetology & Metabolic Syndrome (2016)